Cite
HARVARD Citation
Kumar, A. et al. (2022). Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: a phase II risk-adapted design. Leukemia & lymphoma. 63 (12), pp. 2889-2896. [Online].